Lavo Life Sciences went through Y Combinator in the Winter 2023 batch and describes itself as: AI for drug formulation. As of November 10, 2026, Y Combinator's directory lists it as Inactive (Y Combinator directory entry, January 18, 2023).
Sell to companies like Lavo Life Sciences? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Get the full cited report on Lavo Life Sciences
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
- The Short Answer
- Warning Bells
- Sources: 1 cited
- See all sections
A Full Report on Lavo Life Sciences: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Pitching, partnering or investing alongside them? See who really runs and owns Lavo Life Sciences.
Free to see. No signup.
Watch Lavo Life Sciences
Get an email when Lavo Life Sciences changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Key facts
- · Batch: Winter 2023 · Lavo Life Sciences in the Y Combinator directory
- · Industry: Healthcare · Lavo Life Sciences in the Y Combinator directory
- · Team size: 3 · Lavo Life Sciences in the Y Combinator directory
- · Status: Inactive, as listed by Y Combinator · Lavo Life Sciences in the Y Combinator directory
Lavo Life Sciences went through Y Combinator in the Winter 2023 batch, describing itself as AI for drug formulation. Y Combinator's company directory lists it as Inactive. The directory does not say why a company stopped, and this page does not guess.
- Batch
- Winter 2023
- What they did
- AI for drug formulation
- Industry
- Healthcare
- Team size
- 3
- Status
- Inactive, as listed by Y Combinator
Its batch
Winter 2023 had 278 companies in YC's listing: 203 Active, 36 Acquired, 0 Public and 39 Inactive, so Lavo Life Sciences is one of 39 companies from that batch listed as Inactive (14%). Across YC batches at least two years old, 23% of companies are listed Inactive.
Statuses are Y Combinator's own listing in its public company directory, read on the date shown. YC's directory can drop companies altogether, so the Inactive counts here are a floor, not a full count of companies that stopped. Acquired and Public are as YC lists them; neither says anything about the price or the outcome for founders.
The record: Lavo Life Sciences in the Y Combinator directory. Measured 2026-11-10 from Y Combinator's company directory.
YC Winter 2023All shut-down YC companiesYC outcomes
Want the whole picture on Lavo Life Sciences?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Lavo Life Sciences: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lavo Life Sciences covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for Lavo Life Sciences. With no account yet, you sign up free and land on the result.